YOLFTbeta
Catheter Precision Inc.

Catheter Precision Inc.

VTAK · AMEX · Healthcare / Medical Devices

0.49USD-0.04 (-7.55%)

Price History

Full chart

Market Stats

Previous Close0.53
Open0.57
Day Range0.49 – 0.57
52-Week Range0.1288 – 3.20
Volume213.90K
Market Cap529.51K
P/E (TTM)0.00
Forward P/E0.00
EPS-4.07
Dividend Yield0.00%
Beta0.47
50-Day Avg0.236
200-Day Avg1.07

About

Catheter Precision, Inc. designs, manufactures, and sells medical technologies for the field of cardiac electrophysiology (EP) in the United States and Europe. The company's lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures; and LockeT, a suture retention device that temporarily secure sutures and aid clinicians in locating and removing sutures. Catheter Precision, Inc. was formerly known as Catheter Robotics Inc. The company is based in Fort Mill, South Carolina.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. David A. Jenkins
  • Employees17
  • Headquarters1670 Highway 160 West, Fort Mill, SC, United States, 29708, USA
  • Websitehttps://www.catheterprecision.com

Leadership

  • Mr. David A. JenkinsCEO, Chief Commercial Officer & Executive Chairman · b. 1958
  • Mr. Philip J. AndersonChief Financial Officer & Secretary · b. 1968

Financials

Income Statement

Currency: USD2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue5.98M5.87M6.26M7.20M4.41M22.00K14.00K442.00K420.00K819.00K
Growth (%)--1.77%+6.59%+15.06%-38.81%-99.50%-36.36%+3057.14%-4.98%+95.00%
Cost of Revenue3.14M4.17M4.21M8.85M5.48M1.56M161.00K30.00K42.00K63.00K
Gross Profit2.84M1.71M2.05M-1.65M-1.08M-1.54M-147.00K412.00K378.00K756.00K
Gross Margin47.49%29.05%32.78%-22.93%-24.45%-6990.91%-1050.00%93.21%90.00%92.31%
Operating Expense7.04M19.46M33.21M56.08M34.98M27.73M26.81M78.53M11.62M12.94M
Operating Income-4.20M-17.76M-31.16M-57.73M-36.06M-29.27M-26.96M-78.12M-11.24M-12.18M
Operating Margin-70.25%-302.56%-498.00%-801.92%-818.59%-133027.27%-192578.57%-17673.98%-2676.90%-1487.30%
EBITDA-4.10M-17.54M-30.54M-55.98M-33.69M-27.70M-22.37M-15.11M-11.30M-17.11M
EBITDA Margin-68.66%-298.84%-488.03%-777.61%-764.90%-125913.64%-159771.43%-3418.55%-2690.95%-2089.01%
Net Income-4.20M-17.77M-30.83M-56.96M-36.05M-25.07M-26.86M-70.57M-16.64M-17.18M
Net Income Margin-70.31%-302.64%-492.76%-791.18%-818.27%-113954.55%-191892.86%-15966.52%-3962.62%-2098.05%
R&D1.72M4.52M2.78M4.53M9.01M12.25M6.39M475.00K272.00K862.00K
R&D as % of Total Revenue28.70%76.97%44.37%62.93%204.49%55695.45%45657.14%107.47%64.76%105.25%
Interest Expense3.00K4.00K14.00K250.00K108.00K10.00K3.08M091.00K281.00K
Interest Expense % of Total Revenue0.05%0.07%0.22%3.47%2.45%45.45%21983.74%0.00%21.67%34.31%

Balance Sheet

Currency: USD2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets5.84M11.27M74.03M44.08M33.44M21.04M16.84M30.74M27.77M15.86M
Total Liabilities6.22M18.88M7.33M10.93M12.29M7.37M7.58M9.54M16.01M9.21M
Total Equity-380.00K-7.62M66.70M33.15M21.15M13.67M9.26M21.19M11.76M7.05M
Cash3.92M8.24M64.31M14.58M23.91M15.04M15.86M3.56M2.87M88.00K
Total Debt107.00K63.00K850.00K3.50M4.88M2.26M124.17K372.00K1.79M3.85M
Net Debt-3.81M-8.17M-63.47M-11.09M-19.02M-12.78M-15.86M-3.19M-1.08M3.76M

Cash Flow

Currency: USD2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-1.89M-5.52M-18.51M-33.17M-28.30M-27.63M-22.57M-20.62M-9.27M-8.30M
Investing Cash Flow-210.00K-547.00K-582.00K-16.03M15.93M3.80M21.00K-61.00K-67.00K167.00K
Financing Cash Flow5.37M10.39M75.17M-526.00K21.69M14.96M23.36M8.39M8.65M5.34M
Capital Expenditure210.00K547.00K582.00K268.00K67.00K265.00K17.00K76.00K67.00K17.00K
Free Cash Flow-2.10M-6.07M-19.09M-33.44M-28.37M-27.89M-22.59M-20.70M-9.34M-8.31M
Dividends Paid------907.16K-5.16M-
FCF to OCF111.13%109.90%103.14%100.81%100.24%100.96%100.08%100.37%100.72%100.20%
Dividend Paid to FCF-------4.02%--55.24%-

Earnings

Report DateAug 29, 2018Nov 13, 2018Mar 14, 2019May 13, 2019Aug 28, 2019Nov 29, 2019Mar 10, 2020May 13, 2020Aug 11, 2020Nov 12, 2020Mar 16, 2021May 11, 2021Aug 16, 2021Nov 15, 2021Mar 23, 2022May 16, 2022Aug 15, 2022Nov 16, 2022Mar 14, 2023Jun 2, 2023Aug 14, 2023Dec 21, 2023Mar 29, 2024May 6, 2024Aug 14, 2024Nov 14, 2024Mar 27, 2025May 5, 2025Aug 11, 2025Nov 13, 2025May 18, 2026Aug 14, 2026Nov 12, 2026
EPS Estimate0.00-0.35-0.38-0.38-0.79-1.01-1.02-0.35-0.23-3.13-2.50-2.94-2.88-0.79-0.85-0.17-0.16-8.00-8.00-0.34-3.02-0.23-2.30-7.98-4.94-3.42-0.200.050.020.08---
EPS Actual-1.04-0.59-1.18-1.16-1.16-1.30-0.72-0.56-0.43-3.25-3.61-2.48-1.28-0.67-1.23-0.27-13.00-4.36-3.83-24.65-11.50-0.28-2.80-68.40-105.83-38.19-1.35-0.36-5.93-1.70-1.39-0.92-
Surprise--68.57%-210.53%-205.26%-46.84%-28.71%29.41%-60.00%-86.96%-3.83%-44.40%15.65%55.56%15.19%-43.86%-58.82%-8025.00%45.50%52.13%-7150.00%-280.79%-21.74%-21.74%-757.14%-2042.31%-1016.67%-573.75%-817.00%-29750.00%-2225.00%---
Timing-------------------After-hours-After-hoursAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursAfter-hours-----

Key Statistics & Ratios

Market Cap529.51K
Enterprise Value12.36M
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.28
Price / Book0.03
EPS-4.07
Book Value4.87
Revenue (TTM)1.92M
Gross Profit (TTM)914.00K
EBITDA-10.17M
Profit Margin0.00%
Operating Margin-388.13%
Return on Equity-111.35%
Return on Assets-24.15%
Shares Outstanding3.61M
Shares Float11.83M
Beta0.47
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Strong Buy
Based on 1 analystsTarget 2.00
  • Strong Buy
    1

Stock Splits

  • Aug 15, 20251:19
  • Jul 15, 20241:10
  • Oct 3, 20221:50
  • Nov 17, 20201:25